Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation

P. Vitulo, T. Oggionni, A. Cascina, E. Volpini, E. Arbustini, F. Meloni, A. M. D'Armini, M. Viganò, A. Rossi (Pavia, Italy)

Source: Annual Congress 2001 - Issues in lung transplantation
Session: Issues in lung transplantation
Session type: Thematic Poster Session
Number: 1982

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Vitulo, T. Oggionni, A. Cascina, E. Volpini, E. Arbustini, F. Meloni, A. M. D'Armini, M. Viganò, A. Rossi (Pavia, Italy). Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation. Eur Respir J 2001; 16: Suppl. 31, 1982

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Immunosuppressive therapy after human lung transplantation
Source: Eur Respir J 2004; 23: 159-171
Year: 2004



Immunosuppressive therapy after human lung transplantation
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=105
Year: 2003

Basiliximab induction reduces the incidence of acute rejection in lung transplant patients
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018

LATE-BREAKING ABSTRACT: Challenging immunosuppression treatment in lung transplant patients with kidney failure: Rescue therapy with basiliximab?
Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Year: 2015


Evaluation of early conversion to prolonged-release tacrolimus in lung transplantation.
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018


LATE-BREAKING ABSTRACT: Long-term survival with extracorporeal photochemotherapy in lung transplant rejection patients not responsive to conventional treatment.
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014

Aerosolized liposomal cyclosporine A for treatment of progressive allograft dysfunction following lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013


Azithromycin (Azi) treatment for chronic allograft dysfunction after lung transplantation (LTx)
Source: Annual Congress 2003 - Bronchiolitis obliterans: diagnosis and treatment
Year: 2003


Effect of TLI during azithromycin treatment in patients with BOS after lung transplantation
Source: Eur Respir J 2007; 30: Suppl. 51, 174s
Year: 2007

Early sirolimus immunosuppression is safe in lung transplantation
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012

Mycophenolate mofetil reduces alveolar inflammation and acute rejection and improves overall outcome after lung transplantation
Source: Eur Respir J 2006; 28: Suppl. 50, 724s
Year: 2006

Comparison of post renal transplant tuberculosis cases receiving conventional immunosupressive therapy and mycophenolat mofetil (MMF) and/or tacrolimus (TAC)
Source: Eur Respir J 2003; 22: Suppl. 45, 157s
Year: 2003

Treatment options in chronic GVHD and CLAD post lung transplantation
Source: International Congress 2016 – Chronic graft-versus-host disease and chronic allograft dysfunction after lung transplantation: similarities and dissimilarities
Year: 2016


Efficacy and toxicity of azathioprine plus corticosteroids in 32 patients with chronic persistent sarcoidosis
Source: Eur Respir J 2004; 24: Suppl. 48, 712s
Year: 2004

Mycophenolate mofetil (MMF) rescue therapy in lung transplantation: results and pharmacokinetics
Source: Eur Respir J 2002; 20: Suppl. 38, 348s
Year: 2002

A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation
Source: Eur Respir J 2011; 37: 164-172
Year: 2011



Pulmonary graft-versus-host disease (GVHD) post- stem cell transplant (SCT) for haematological malignancies: Good response to treatment if diagnosed early
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012

12 month follow-up of lung recipients with chronic allograft dysfunction treated with extracorporeal photopheresis (ECP)
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011


Negative consequences of immunosuppressive therapy on bronchial healing following lung transplantation (LTx)
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013

Azithromycin treatment in patients with BOS after lung transplantation
Source: ISSN=ISSN 1810-6838, ISBN=, page=178
Year: 2005